CASTEL SAN PIETRO, September 11, 2025 - Medacta Group SA (“Medacta” SIX: MOVE) continues the rollout of its expanded Personalized Sports Medicine Portfolio at the 42nd AGA Congress (Gesellschaft für Arthroskopie und Gelenkchirurgie - Society for Arthroscopy and Joint Surgery) in Hamburg, Germany, highlighting its commitment to advancing personalized repair and reconstruction solutions designed to restore natural joint motion and improve patient outcomes.
At Booth 214, visitors can discover Medacta’s latest innovations, designed to make sports medicine procedures simpler, more reproducible, and effective.
Among them is the debut of QuickStitch, an intuitive, reliable, and user-friendly device engineered for precise suture placement in meniscal Inside-Out tissue repair, helping surgeons preserve the meniscus and restore joint function with confidence. “Inside-Out Next Level – fits perfectly in the hand, is easy and intuitive to use, and reduces stitching time. A very well thought-out, innovative tool that makes the inside-out stitch as easy as an all-inside stitch,” said Dr. Björn Drews, Munich.
The expanded portfolio also features:
Today, a lunch symposium led by Prof. Christian Fink and Dr. Robert Smigielski (Room Y.1, Congress Center Hamburg) will highlight Medacta’s personalized solutions through complex knee case studies, including advanced management of meniscal tears, ACL re-ruptures with medial instability, and patellar re-dislocation after Medial Patellofemoral Ligament reconstruction.
“These advances underscore our commitment to innovation and clinical value. The future of sports medicine is personalization—helping every surgeon deliver tailored care and every patient return to activity with confidence,” said Francesco Siccardi, CEO of Medacta.
All solutions are supported by the M.O.R.E. Institute, offering world-class, tailored educational programs that guide surgeons in adopting the latest advancements. With Medacta, the surgeon is never alone.
Discover more on the Medacta Sports Medicine website.
CONTACT
ABOUT MEDACTA
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 70 countries. Follow us on Medacta.com, Medacta TV, YouTube, LinkedIn and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The products and services listed below may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts.
